Stock listing

TLX1N Stock Price, News, Filings & Events — Telix Pharmaceuticals Limited

Selected listing: TLX1N · BIVA · MXN · MX

The TLX1N:BIVA listing represents Telix Pharmaceuticals Limited, a biopharmaceutical company focused on developing and commercializing innovative radiopharmaceuticals for the treatment of cancer. Recently, Telix has been active in advancing its clinical programs and expanding its product pipeline, which aims to address unmet medical needs in oncology. The company regularly updates its investors through filings and news releases, providing insights into its research progress and strategic initiatives. As the market for targeted cancer therapies continues to grow, Telix is positioned to play a significant role in this evolving landscape.

TLX1N:BIVAMXNMXUpdated July 21, 2026
Telix Pharmaceuticals Limited logo
Ticker
TLX1/N:BIVA
Asset type
Stock
Market cap
$3.71B
Sector
Health Technology
Industry
Biotechnology
Exchange
BIVA
Currency
MXN

Telix Pharmaceuticals Limited TLX1N:BIVA stock context

The TLX1N:BIVA listing represents Telix Pharmaceuticals Limited, a biopharmaceutical company focused on developing and commercializing innovative radiopharmaceuticals for the treatment of cancer. Recently, Telix has been active in advancing its clinical programs and expanding its product pipeline, which aims to address unmet medical needs in oncology. The company regularly updates its investors through filings and news releases, providing insights into its research progress and strategic initiatives. As the market for targeted cancer therapies continues to grow, Telix is positioned to play a significant role in this evolving landscape.

Research Telix Pharmaceuticals Limited

Alternate listings